Iqvia

Reimagine iqvia development by intelligently connecting data, technology, and analytics to optimize your trials.

IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. IQVIA is the result of the merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider [9] The name of the modern company honors the legacy organizations. IMS Health was best known for its collection of healthcare information spanning sales, de-identified prescription data, medical claims, electronic medical records [10] and social media. Quintiles was the world's largest provider of biopharmaceutical development and commercial outsourcing services. The company offered clinical data management, clinical trial execution services, pharmaceuticals, drug development, financial partnering, and commercialization expertise to companies in the biotechnology, pharmaceutical and healthcare sectors.

Iqvia

Innovative emerging biopharma and biotech companies are driving the drug development pipeline; competition for funding and resources is fierce. IQVIA Biotech delivers flexible clinical development solutions designed for the specific needs of biotech companies. When you partner with our clinical development team you gain expertise from more than two decades of running clinical trials exclusively for biotech companies, plus access to IQVIA's unparalleled data and technology. We understand the unique challenges and opportunities you face. From drug development strategy to trial design and execution, we draw on this experience to put together the right solution, and the right team, for you. The report provides clarity on the current landscape of EBP companies and their emerging product pipelines, as well as associated clinical trial activity and levels of trial success. In addition, the report focuses on the financial deals, technology and approaches to enable and accelerate these companies' efforts, profiling the drugs these companies have launched or originated, and an assessment of the success of launches in recent years including nuances beyond simply sales uptake. On the surface, your milestones may look the same as large pharma's. But we know that you face very different questions along your journey. The answers to those questions can impact not only your asset's probability of success, but that of your overall company.

Real results. Explore Now.

.

We want to help make extraordinary things possible for patients. We are inspired by their stories, and it is our mission to accelerate innovations that enable better outcomes. Every day, we work alongside customers and partners to unleash potential and help improve health around the world. We aim to bring out the best in each other and our diverse expertise. We maximize our positive impact by working together. We are always learning and seeking opportunities for personal, professional, and organizational growth. IQVIA is focused on making intelligent connections for customers across the entire healthcare ecosystem to help you drive healthcare forward.

Iqvia

Orchestrate your clinical trials with transformative technologies to accelerate innovation, optimize efficiency, and deliver new treatments and vaccines to global markets faster. Molecule to market decisions. C-Suite decisions. Multi-stakeholder decisions. Getting treatments to market is increasingly complex, and market demands never stop growing. Clinical trials, launch planning, brand marketing, customer engagement, and patient support are more challenging to manage than ever before. By seamlessly connecting people, data, analytics and technology, IQVIA helps you accelerate the journey from data to insights to action so you can unleash new opportunities faster. The IQVIA Orchestrated Clinical Trials seamlessly integrates best of breed, modular, interoperable technologies proven to optimize efficiency and enhance trial outcomes. Digital Planning Suite Accurately predict study timeline, budget, and trial performance. Digital Site Suite Orchestrate better site-sponsor relationships.

Lyrics i just wanna feel this moment

Clinical Outsourcing Group New England. Toggle limited content width. Learn more. Institute Reports. Dedicated to your success. Used under license. Ayotte Cato Institute". Flexible clinical solutions for biotech Your milestones. Diversity and inclusion in oncology clinical trials. Excellence in Immuno-Oncology Clinical Trials. Connecting intelligence to advance healthcare From connecting our data, expertise, and technologies to bringing the right stakeholders together, IQVIA is committed to making connections that help customers accelerate results and improve patient outcomes.

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Read Edit View history. Institute Reports. In December , U. Navigating the Complex Oncology Landscape. Email Us. Download as PDF Printable version. Find out about the latest from IQVIA data scientists, doctors, researchers, and other experts on the topics that matter to you. Help drive healthcare forward We want to make a difference for patients. Insight Briefs. Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. Advancing Pediatric Cancer Research. We understand the unique challenges and opportunities you face. Quintiles was the world's largest provider of biopharmaceutical development and commercial outsourcing services.